drugset / Trial / NCT00590863

Combining Medications to Enhance Depression Outcomes

NCT00590863

Phase 4 Completed 665 enrolled National Institute of Mental Health (NIMH)
RandomizedParallel-groupSingle-blindTreatment

Summary

This study will compare whether a combination of antidepressant medications is better than one antidepressant medication alone when given as initial treatment for people with chronic or recurrent major depressive disorder.

Timeline

Start
2008-03
Primary completion
2009-09
Completion
2009-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupropion Small molecule 150 mg Oral
Comparator Bupropion Small molecule 450 mg Oral
Comparator Escitalopram Small molecule 10 mg Oral
Comparator Escitalopram Small molecule 20 mg Oral
Comparator Mirtazapine Other / unclassified 15 mg Oral
Comparator Mirtazapine Other / unclassified 45 mg Oral
Comparator Venlafaxine Small molecule 75 mg Oral
Comparator Venlafaxine Small molecule 225 mg Oral